| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.053 | 0.3 |